Qilian International Holding Group Limited – NASDAQ:QLI

Add to watchlist

$5.4

-0.12

-2.35%

Market closed

Open in about 14 hours

+700.29%

month

+601.87%

quarter

+508.03%

year

Market Cap	38.68M
Enterprise value	9.18M

P/E	20.18
EV/Sales	0.14
EV/EBITDA	2.00
Price/Sales	0.33
Price/Book	0.40
PEG ratio	-0.30
EPS	-0.17

Revenue	95.62M
EBITDA	891.24K
Income	-6.29M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	1.66%
Oper. margin	5.13%
Gross margin	9.6%
EBIT margin	5.13%
EBITDA margin	0.93%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Qilian International Holding Group Limited (NASDAQ:QLI): Profit margin
Jun 2022	16.38M	494.41K	3.02%
Sep 2022	32.76M	988.83K	3.02%
Mar 2023	29.16M	495.52K	1.7%
Sep 2023	17.30M	-8.27M	-47.82%

Qilian International Holding Group Limited (NASDAQ:QLI): Payout ratio
Payout ratio	0%

Qilian International Holding Group Limited (NASDAQ:QLI): Dividend Yield
2019
2020
2021
2022
2023	1.27%

Qilian International Holding Group Limited (NASDAQ:QLI): Debt to assets
Sep 2022	64526617	9.56M	14.82%
Dec 2022	64233784	9.49M	14.79%
Mar 2023	64233784	9.49M	14.79%
Sep 2023	51257994	6.68M	13.04%

Qilian International Holding Group Limited (NASDAQ:QLI): Cash Flow
Jun 2022	4.23M	89.70K	-4.53M
Sep 2022	8.46M	179.41K	-9.07M
Mar 2023	-448.99K	-2.26M	-2.90M
Sep 2023	761.20K	-2.42M	-74.63K

Qilian International Holding Group Limited alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Qilian International Holding Group Limited
Employees

Qilian International Holding Group Limited (NASDAQ:QLI): Employee count
Aug 2023	345
Sep 2023	345
Oct 2023	345
Nov 2023	345
Dec 2023	345
Jan 2024	345
Feb 2024	345
Mar 2024	298
Apr 2024	298
May 2024	298
Jun 2024	298
Jul 2024	298

Qilian International Holding Group Limited
Hedge Funds Holdings Q1 2023

0.01% -0.08%

of QLI is owned by hedge funds

1 -2

hedge funds hold QLI stock

1.80K -29.35K

shares is hold by hedge funds

QLI hedge funds holdings changes

Qilian International Holding Group Limited
Executives

Insider	Age	Since	Compensation
Mr. Zhanchang Xin (1967) Chairman, Pres & Chief Executive Officer	58		$17,940
Ms. Haiping Shi (1973) Chief Financial Officer & Director	52		$14,580

Qilian International Holding Group Limited
Latest News

Tuesday, 13 August 2024
08:00	Qilian International Holding Group Ltd. Announces Trading Ticker Symbol to "BGM"	prnewswire.com
Friday, 12 July 2024
08:30	Qilian International Holding Group Ltd Regained Compliance with Nasdaq's Minimum Bid Price Rule	prnewswire.com
Tuesday, 18 June 2024
08:30	Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split	prnewswire.com
Friday, 17 May 2024
10:00	Qilian International plans to adjust industrial investment	prnewswire.com
Friday, 12 January 2024
07:30	Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule	prnewswire.com
Thursday, 16 September 2021
16:10	Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2021	GlobeNewsWire

Frequently Asked Questions (FAQ)

What's the price of Qilian International Holding Group Limited stock today?

One share of Qilian International Holding Group Limited stock can currently be purchased for approximately $5.4.
When is Qilian International Holding Group Limited's next earnings date?

Unfortunately, Qilian International Holding Group Limited's (QLI) next earnings date is currently unknown.
Does Qilian International Holding Group Limited pay dividends?

Yes, Qilian International Holding Group Limited pays dividends and its trailing 12-month yield is 8.23% with 0% payout ratio. The last Qilian International Holding Group Limited stock dividend of undefined was paid on 25 Sep 2025.
How much money does Qilian International Holding Group Limited make?

Qilian International Holding Group Limited has a market capitalization of 38.68M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 28.35% to 46.47M US dollars.
What is Qilian International Holding Group Limited's stock symbol?

Qilian International Holding Group Limited is traded on the NASDAQ under the ticker symbol "QLI".
What is Qilian International Holding Group Limited's primary industry?

Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
How do i buy shares of Qilian International Holding Group Limited?

Shares of Qilian International Holding Group Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Qilian International Holding Group Limited's key executives?
Qilian International Holding Group Limited's management team includes the following people:
- Mr. Zhanchang Xin Chairman, Pres & Chief Executive Officer(age: 58, pay: $17,940)
- Ms. Haiping Shi Chief Financial Officer & Director(age: 52, pay: $14,580)
How many employees does Qilian International Holding Group Limited have?

As Jul 2024, Qilian International Holding Group Limited employs 298 workers.
When Qilian International Holding Group Limited went public?

Qilian International Holding Group Limited is publicly traded company for more then 4 years since IPO on 12 Jan 2021.
What is Qilian International Holding Group Limited's official website?

The official website for Qilian International Holding Group Limited is qlsyy.net.
How can i contact Qilian International Holding Group Limited?

Qilian International Holding Group Limited can be reached via phone at +86 28 6477 5180.

Qilian International Holding Group Limited

qlsyy.net

Exchange:

NASDAQ

Full time employees:

298

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.

+86 28 6477 5180

Jiuquan Eco & Tech Dev Zn
Jiuquan, 735000

CIK: 0001779578
ISIN: KYG7307E1070
CUSIP: G7307E107